Cited by 338Metabolism, Diabetes, and CancerGrowth Hormone and Insulin-like Growth FactorsEstrogen and related hormone effects

Elevated insulin receptor content in human breast cancer

Open access
Papa, V, Pezzino, V, Costantino, A, Belfiore, A, Giuffrida, D, Frittitta, L, Vannelli, G B, Brand, R +2 more·1990·Journal of Clinical Investigation

Abstract

The growth of breast cancer cells is under the regulation of hormones, growth factors, and their receptors. In the present study, we have employed a new, sensitive, and specific radioimmunoassay for the direct measurement of insulin receptors in surgical specimens of breast cancers. In 159 specimens the insulin receptor content was 6.15 +/- 3.69 ng/0.1 mg protein. This value was more than sixfold higher than the mean value found in both 27 normal breast tissues obtained at total mastectomy (0.95 + 0.68, P less than 0.001) and in six normal specimens obtained from reduction mammoplasty (0.84 +/- 0.78, P less than 0.001). The insulin receptor content in breast cancer tissues was also higher than in any normal tissue investigated including liver (Pezzino, V., V. Papa, V. Trischitta, A. Brunetti, P.A. Goodman, M.K. Treutelaar, J.A. Williams, B.A. Maddux, R. Vigneri, and I.D. Goldfine, 1989. Am. J. Physiol. 257:E451-457). The insulin receptor in breast cancer retained its ability to both bind insulin and undergo insulin-induced tyrosine kinase activation. Immunostaining of the specimens revealed that the insulin receptor was present in malignant epithelial cells, but was not detected in stromal and inflammatory cells. Univariant analysis revealed that the insulin receptor content of the tumors correlated positively with tumor size (P = 0.014), histological grading (P = 0.030), and the estrogen receptor content (P = 0.035). There were no significant correlations between insulin receptor content and the age, body weight, menopausal status, and nodal involvement of the patients. These studies indicate, therefore, that the insulin receptor content is increased in breast cancers and raise the possibility that the insulin receptor may have a role in the biology of these tumors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci114868

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Insulin receptors are frequently expressed by breast cancer cells.

    “As has been found in other cancers, insulin receptors are frequently expressed by breast cancer cells (59).”

    From Diabetes and Cancer (2010) · cites this paper as [59]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Scholl, S., and M. E. Lippmann. 1984. Methods and clinical use of receptor assay. In Breast Cancer: Diagnosis and Management. G. Bonadonna, editor. John Wiley & Sons, New York. 74-108.
  2. Legha, S. S. 1988. Tamoxifen in the treatment ofbreast cancer. Annals Intern. Med. 109:219-228.
  3. DeVita V. T., Jr., S. Hellman, and S. A. Rosenberg, editors. J. B. Lippincott Co., Philadelphia. 49-65.
  4. Sternberger, L. A. 1979. The unlabeled antibody peroxidase- antiperoxidase (PAP) method. In Immunocytochemistry. L. A. Stem- berger, editor. John Wiley & Sons, New York. 104-112.

Cited by

Sorted by citations

Authors
Papa, V, Pezzino, V, Costantino, A., Belfiore, A., Giuffrida, D., Frittitta, L., Vannelli, G. B., Brand, R., Goldfine, I. D., & Vigneri, R.
Affiliations
  • University of Catania (IT)
  • University of California, San Francisco (US)
Venue
Journal of Clinical Investigation
Published
1990-11-01
Volume
86
Issue
5
Pages
1503-1510
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1984532045
Cited by
338
References
46
Citations by year
2026: 4 · 2025: 4 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 13 · 2020: 19 · 2019: 14 · 2018: 14 · 2017: 10 · 2016: 12 · 2015: 16 · 2014: 13 · 2013: 19 · 2012: 17
FWCI
2.43
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Florence Research (University of Florence) (submittedVersion)
Funders
  • Consiglio Nazionale delle Ricerche
  • Associazione Italiana per la Ricerca sul Cancro
  • Regione Siciliana
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Keywords
insulin receptor, breast cancer, insulin receptor tyrosine kinase, tumor growth control, estrogen receptor, tumor size, histological grading, malignant epithelial cells, radioimmunoassay
MeSH terms
Binding, Competitive, Breast Neoplasms, Female, Humans, Lymphatic Metastasis, Menopause, Radioimmunoassay, Receptors, Estrogen, Receptor, Insulin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review